Search

2550 results
Article

15 Jun 2022

We respond to research that suggests drugs that neutralise progesterone activity could be a potential risk-reducing treatment for women with altered BRCA genes

In response to research published in Genome Medicine, and part-funded by Breast Cancer Now, which suggests drugs that neutralise progesterone activity could be a potential risk-reducing treatment for women with altered BRCA genes, Dr Kotryna Temcinaite, Senior Research Communications Manager at Breast Cancer Now, said: